US jobs slow to 57k, labor participation drops. Bonds may rally as inflation cools.
NVDA's price reflects lost share; Goldman sees bargain, others eye $300. Is it time to buy?
Novartis snaps up Myricx Bio for $1.1B upfront, potential $1.5B total, boosting its ADC pipeline.
Saudi Arabia slashes oil prices by $11, steepest cut in 26 yrs. Market weakness bites, impacting energy valuations.
SK Hynix eyes $28B US IPO, riding AI demand. Huge returns potential, but IPO valuation risks loom.
Oil prices hold steady as supply concerns ease. Citi forecasts Brent at $60/bbl by year-end.
AI bets pay off! Millennium-backed trader nets 61% return, riding the AI wave.
Sponsored
Must Read